80.23

1.79% 1.3345

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $80.23, with a volume of 186.11K. It is up +1.79% in the last 24 hours and down -23.43% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Previous Close:

$78.90

Open:

$79.62

24h Volume:

186.11K

Relative Volume:

0.31

Market Cap:

$2.31B

Revenue:

$267.23M

Net Income/Loss:

$-83.50M

P/E Ratio:

-25.80

EPS:

-3.11

Net Cash Flow:

$-59.99M

1W Performance:

-11.44%

1M Performance:

-23.43%

6M Performance:

-36.39%

1Y Performance:

-18.99%

1-Day Range:

$79.59

$82.83

1-Week Range:

$78.39

$90.88

52-Week Range:

$55.17

$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1113)

Industry

Diagnostics & Research (53)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,000

Twitter

Next Earnings Date

2025-02-18

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	80.08	2.28B	267.23M	-83.50M	-59.99M	-3.11
TMO Thermo Fisher Scientific Inc	513.05	192.99B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	208.13	148.11B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	656.75	52.49B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	115.90	35.28B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	317.29	31.33B	3.17B	642.63M	516.49M	10.77

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

Feb 25, 2026

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz

Feb 25, 2026

Why GeneDx Holdings (WGS) Is Down 11.3% After Reaffirming 2026 Guidance And Narrowing 2025 Losses - simplywall.st

Feb 25, 2026

GeneDx to Participate in Upcoming Investor Conferences - Yahoo Finance

Feb 25, 2026

Feb 24, 2026

How The GeneDx Holdings (WGS) Narrative Is Shifting With GenomeDx Prenatal And Valuation Expectations - Yahoo Finance

Feb 24, 2026

Aug PreEarnings: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stock2025 Growth vs Value & Weekly Momentum Picks - baoquankhu1.vn

Feb 24, 2026

These Analysts Slash Their Forecasts On GeneDx After Q4 Results - Benzinga

Feb 24, 2026

GeneDx stock slips premarket as analysts trim targets after 2025 results and 2026 outlook - Bez Kabli

Feb 24, 2026